MMSI
Merit Medical Systems Inc
87.30$
+2.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 25.7% | 26.2% | 25.8% | 28.4% | 26.5% | 25.9% | 25.8% | 29.3% | 31.8% | 47.7% | 38.2% | 38.7% | |
| 1.0% | 0.5% | 2.0% | 2.9% | 4.2% | 2.5% | 3.4% | 4.1% | 3.5% | 25.2% | 15.6% | 16.7% | |
| 1.0% | 0.5% | 2.0% | 2.9% | 4.2% | 2.5% | 3.4% | 4.1% | 3.5% | 25.3% | 15.6% | 16.7% | |
| 10.8% | 10.0% | 9.2% | 10.4% | 9.3% | 9.6% | 9.5% | 10.5% | 10.7% | 8.1% | 8.6% | 8.3% | |
| 12.3% | 13.6% | 12.8% | 14.0% | 12.2% | 12.8% | 11.9% | 13.5% | 16.0% | 13.1% | 12.7% | 12.4% | |
| 32.7% | 34.4% | 29.3% | 26.3% | 20.5% | 26.1% | 23.0% | 26.5% | 23.0% | – | – | – | |
| 24.7% | 23.7% | 22.5% | 21.4% | 20.7% | 20.1% | 21.8% | 21.9% | 21.6% | 16.4% | 19.2% | 18.9% | |
| 14.8% | 14.0% | 19.3% | 20.4% | 28.6% | 25.3% | 22.1% | 19.4% | 16.6% | 14.0% | 20.6% | 20.0% | |
| 41.7% | 40.1% | 47.2% | 39.2% | 42.4% | 45.9% | 42.4% | 36.9% | 31.2% | 48.3% | 43.0% | 41.0% | |
| 10.1% | 11.3% | 9.4% | 10.4% | 10.8% | 10.3% | 11.1% | 14.3% | 13.3% | 8.8% | 8.9% | 8.9% | |
| 1.3% | 1.3% | 1.1% | 1.8% | 1.4% | 1.7% | 2.0% | 1.8% | 2.0% | 0.5% | 0.4% | 0.4% | |
| 4.0% | 4.9% | 3.2% | 3.1% | 3.3% | 3.1% | 3.0% | 3.4% | 4.1% | 2.8% | 2.8% | 2.3% | |
| 28.7% | 25.4% | 33.3% | 23.3% | 23.0% | 24.6% | 20.7% | 14.2% | 11.2% | 35.4% | 30.2% | 27.3% | |
| 58.3% | 59.9% | 52.8% | 60.8% | 57.6% | 54.1% | 57.6% | 63.1% | 68.8% | 51.7% | 57.0% | 59.0% | |
| 33.5% | 35.2% | 31.2% | 28.9% | 22.4% | 21.0% | 21.5% | 24.6% | 28.9% | 24.7% | 28.8% | 30.7% | |
| 5.8% | 5.7% | 4.8% | 4.5% | 3.3% | 3.2% | 3.3% | 3.5% | 3.5% | 2.5% | 2.5% | 2.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.